ESR1 and breast carcinoma: Included were invasive, ER-/PR- breast cancer cases (n=449) and controls (n=449) matched on maternal age at index pregnancy, parity, calendar year of serum collection, gestational week of blood collection, and number of freeze/thaw cycles.